• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.51% Nasdaq Up 0.05%

    Amgen Inc. (AMGN)

    -NasdaqGS
    164.78 Down 5.39(3.17%) 12:08PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:170.17
    Open:168.31
    Bid:164.68 x 100
    Ask:164.77 x 100
    1y Target Est:168.81
    Beta:0.43
    Earnings Date:Jan 26 - Jan 30 (Est.)
    Day's Range:163.91 - 169.04
    52wk Range:108.20 - 173.14
    Volume:1,558,532
    Avg Vol (3m):4,078,740
    Market Cap:125.34B
    P/E (ttm):25.94
    EPS (ttm):6.35
    Div & Yield:2.44 (1.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMGN

    Comparison

    Symbol% ChgMkt Cap
    AMGNDown 3.17%125.34B
    JNJUp 0.85%297.97B
    NVSUp 0.69%230.41B
    TEVADown 0.72%49.22B

    Key Statistics

    Forward P/E (1 yr):17.65
    P/S (ttm):6.56
    Ex-Dividend Date:10-Nov-14

    Analysts

    Annual EPS Est (Dec-14) :8.61
    Quarterly EPS Est (Dec-14) :2.05
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.77

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback